News & Updates
Filter by Specialty:
Indomethacin plus somatostatin helps avert pancreatitis in ERCP patients
01 Feb 2023
The addition of somatostatin to rectal indomethacin is safe and effective in the prevention of postendoscopic retrograde cholangiopancreatography (post-ERCP) hypermylasemia and pancreatitis (PEP) in high-risk patients, reports a study.
Indomethacin plus somatostatin helps avert pancreatitis in ERCP patients
01 Feb 2023TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients
20 Jan 2023
Tumour necrosis factor (TNF)-α antagonists show comparable safety as non-TNF biologics in the treatment of inflammatory bowel disease (IBD) in patients with active or recent cancer, as shown in a study.